Related Experiment Video
Updated: Jul 29, 2026
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
[90Y glass microspheres intraradiopraxis of advanced hepatic carcinoma]
1Department of Hepatobiliary Surgery, Union Hospital, Fujian Medical University, Fuzhou 350001.
Objective:
To evaluate intraradiopraxis with (90)Y glass microspheres for advanced hepatic carcinoma.
Method:
28 patients were divided into two group: A treated by (90)Y and hepatic artery embolism and chemotherapy (HAEC) (n = 13), and B by (90)Y and hepatic artery embolism (HAE) (n = 15), and 15 cases (group C) only treated by HACE simultaneously were used as controls. The average age, course, and diameter of tumor were similar in all groups (P > 0.05).
Result:
The effective rate of the group A and B was 61.5% and 66.6% respectively, and that of the group C was only 33.3% (P < 0.001). The average survival time of the group A and B was 9.86 and 11.9 months respectively, and that of the group C was only 4.5 months (P < 0.001).
Conclusion:
The intraradiopraxis with (90)Y glass microsphere would be a valuable method for patients with hypo-leukocyte count, insensitive to chemotherapy or resistant to chemotherapy.
